Sort
261,768 grants matching “gene therapy”
Functional Analysis of Oncogenic Networks in Primary Organoids
$854,573Calvin J Kuo · Stanford University · U01 · FY2015 · CA
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
$854,568Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER
$854,560Dana-Farber Cancer Institute · U01 · FY2000 · CA
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer
$854,530Vincent Sandanayaka · Nirogyone Therapeutics, Llc · R44 · FY2021 · CA
Development of the RXR agonist IRX4204 to treat Multiple Sclerosis and other Immune related Diseases
$854,395Rosh Chandraratna · Io Therapeutics, Inc. · R44 · FY2016 · AI
Regulatory T cells and the tumor microenvironment
$854,385Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R35 · FY2024 · CA
Regulation of y-secretase activity by modulatory proteins
$854,379Yueming Li · Sloan-Kettering Inst Can Research · R01 · FY2022 · AG
RNA modification and innate immune activation in HIV infection
$854,360Hisashi Akiyama · Boston University Medical Campus · R01 · FY2024 · AI
Omics Analyses of HIV and Substance Use Disorder
$854,351Vez Repunte-Canonigo · Scripps Research Institute, The · R01 · FY2022 · DA
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$854,326Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Developing Novel Therapies for High Risk Pediatric Cancers
$854,306Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
OPTIMIZATION OF DOSING REGIMENS OF SULINDAC IN COMBINATION WITH ERLOTINIB FOR SMALL INTESTINAL AND COLON CANCER PREVENTION
$854,290Powell Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2019 · CA
Facility and Web-based Approaches to Lifestyle Change in Resistant Hypertension
$854,215James A. Blumenthal · Duke University · R01 · FY2017 · HL
Zika virus nonstructural protein 5 inhibition of interferon signaling
$854,154Matthew J Evans · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Clinical Trials with Immunotoxins
$854,104Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Analytical Resources Core
$854,035Nathan A Vandergrift · Duke University · P01 · FY2020 · AI
Biophysical and molecular dialogue of glioma cells and the brain microenvironment
$854,013Gabriele Bergers · University Of California, San Francisco · U54 · FY2014 · CA
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
$854,013Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Genomic instability in aging and cancer
$854,009Toren Finkel · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Developing RNA therapeutics for rare neurodevelopmental disorders
$853,987Francesco Lotti · Dayi Therapeutics, Inc. · R42 · FY2025 · HD
Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis
$853,963Gregory Paul Downey · National Jewish Health · UG3 · FY2018 · TR
Intragraft expression to Predict Future GFR Decline in Kidney Transplantation
$853,920Mark D Stegall · Mayo Clinic Rochester · U01 · FY2011 · AI
Using Omics to Understand the Effects of Drug Abuse on HIV Latent Reservoir
$853,917Eric O Johnson · Research Triangle Institute · R61 · FY2020 · DA
Combination Anticancer Nanopreparations of Novel Proapoptotic Drug and siRNA
$853,888Vladimir P Torchilin · Northeastern University · U54 · FY2010 · CA
Mediators of cancer cell homeostasis: intervention targets common to diverse types of cancer
$853,881Hartmut Land · University Of Rochester · R35 · FY2021 · CA